To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC5069 | Enzalutamide (MDV3100) Featured |
MDV3100 is an androgen-receptor (AR) antagonist with IC50 of 36 nM.
More description
|
|
| DC46946 | Atirmociclib(PF-07220060) Featured |
Atirmociclib(PF-07220060) is a potent CDK4/CDK6 inhibitor with a Ki of 0.6 nM and 13.9 nM for CDK4/Cyclin D1 and CDK6/Cyclin D3, respectively.
More description
|
|
| DC70187 | AM237 Featured |
AM237 is a selective TRPC5 channel activator that potently activated homomeric TRPC5:C5 channels (EC50=15–20 nM in Ca2+i assays).AM237 did not activate TRPC4:C4, TRPC4-C1, TRPC5-C1, TRPC1:C5, and TRPC1:C4 channels, or native TRPC1:C4 channels in A498 cells, but potently inhibited EA‐dependent activation of these channels with IC50 values ranging from 0.9 to 7 nM.AM237 (300 nM) did not activate or inhibit TRPC3, TRPC6, TRPV4, or TRPM2 channels.AM237 potentiated TRPC5:C5 channels activation by sphingosine‐1‐phosphate but suppressed activation evoked by (−)‐englerin A (EA).AM237 concentration‐dependently suppressed further activation of Ca2+ influx mediated by EA with IC50 of 13 nM, potentiated TRPC5:C5 activation by S1P.Pico145 is a competitive antagonist of AM237‐mediated TRPC5:C5 activation.
More description
|
|
| DC73563 | E6742 Featured |
E6742 (E6742) is a potent, selective, dual TLR7/8 inhibitor with binding Kd of 1.7 uM/37 nM in ITC assays, respectively, inhibits TLR7/8 agonist CL097 induced reporter activation with IC50 values of 22, 68, and 3.0 nM for hTLR7, mTLR7, and hTLR8, respecti
More description
|
|
| DC23156 | Tofogliflozin Featured |
Tofogliflozin (CSG-452) is a potent, highly selective SGLT2 inhibitor with Ki of 2.9, 14.9, and 6.4 nM against human, rat, and mouse SGLT2, respectively.
More description
|
|
| DC79087 | UNC10415667 Featured |
UNC10415667 is a NSD2 degrader, with a DC50 values of 460 nM. UNC10415667 can be used for the study of cancers driven by NSD2 overexpression or dysregulation, such as multiple myeloma, acute lymphocytic leukemia, and prostate cancer.
More description
|
|
| DC20410 | Hydrazinocurcumin Featured |
Hydrazinocurcumin is a synthetic curcumin derivative that inhibits the proliferation of bovine aortic endothelial cells (BAECs) with IC50 of 520 nM without cytotoxicity, inhibits STAT3 phosphorylation and downregulates an array of STAT3 downstream targets.
More description
|
|
| DC21684 | Ryuvidine Featured |
Ryuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM).
More description
|
|
| DCL0029 | PL41 Featured |
PL41 is a piperazine-containing phosphoramidate ionizable lipid studied for macrophage mRNA delivery and in situ CAR-M engineering. The optimized PL41-PG LNP contains DSPG and was investigated for TREM2-dependent delivery, receptor degradation and macrophage reprogramming in malignant ascites. Evidence comprises cell assays, mouse models and ex vivo patient-derived samples. Reported nanoparticle activity depends on the full formulation and RNA cargo; DC Chemicals supplies the PL41 lipid for research use.
More description
|
|
| DC20942 | DB04760 Featured |
DB04760 is a potent, highly selective, non–zinc-chelating MMP-13 inhibitor with IC50 of 8 nM, displays high selectivity over other MMPs.
More description
|
|
| DC68241 | MA32 Featured |
MA32 is a small-molecule binder of CAPON with a Kd of 74 μM. MA32 can be used for Alzheimer’s disease research.
More description
|
|
| DC10675 | LY3200882 Featured |
LY3200882 is a novel, highly selective TGFβRI small molecule inhibitor.
More description
|
|
| DC8903 | Troglitazone Featured |
Troglitazone(CS-045), PPARγ agonist, is an anti-diabetic thiazolidinedione (TZD) with anti-inflammatory and anti-tumor activity.
More description
|
|
| DCL0028 | HX1 Featured |
HX1 is a hydroxyzine-derived ionizable lipid with acetal-containing tails, studied in lipid nanoparticles for brain mRNA delivery and CRISPR–Cas9 delivery. It was the lead in the reported in vivo brain-delivery screen; evidence is preclinical and formulation-dependent.
More description
|
|
| DC73945 | CKi-4 Featured |
Creatine kinase inhibitor CKi-4 is a selective, covalent inhibitor of creatine kinases (CKs), inhibits recombinant creatine kinase B (CKB) phosphotransfer activity with IC50 of 0.3 uM, depletes creatine phosphagen energetics in cells.
More description
|
|
| DC73946 | CKi-6 Featured |
CKi-6 is a selective, covalent inhibitor of creatine kinases (CKs), inhibits recombinant creatine kinase B (CKB) phosphotransfer activity with IC50 of 0.6 uM, depletes creatine phosphagen energetics in cells.
More description
|
|
| DC28717 | CKI-7 Featured |
CKI-7 is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8.5 μM. CKI-7 is a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1). CKI-7 has a much weaker effect on casein kinase II and other protein kinases.
More description
|
|
| DC72399 | Acetoacetic acid Featured |
Acetoacetic acid is an endogenous metabolite present in Cerebrospinal_Fluid and Blood that can be used for the research of Meningitis, Pregnancy, 3 Hydroxy 3 Methylglutaryl CoA Lyase Deficiency, Preeclampsia/Eclampsia, Diabetes Mellitus Type 2, Glucose Transporter Type 1 Deficiency Syndrome and Succinyl CoA:3 Oxoacid CoA Transferase Deficiency.
More description
|
|
| DCL0025 | DSPE-PEG3400-TFP Featured |
DSPE-PEG3400-TFP is a functionalized PEG lipid combining a DSPE lipid anchor with a nominal PEG3400 spacer and a terminal TFP group. It is offered for bioconjugation, surface-functionalization and lipid-based delivery research.
More description
|
|
| DC23963 | QL47 Featured |
A potent, selective, and irreversible BTK inhibitor with IC50 of 7 nM.
More description
|
|
| DC49423 | Desfuroylceftiofur Featured |
Desfuroylceftiofur is an active metabolite of Ceftiofur which is a broad-spectrum cephalosporin antibiotic. Desfuroylceftiofur is active against gram-positive and gram-negative bacteria.
More description
|
|
| DC12017 | NKY80 Featured |
NKY80 is a potent, selective and non-competitive adenylyl cyclase (AC) type V isoform inhibitor with IC50s of 8.3 µM, 132 µM and 1.7 mM for type V, III and II, respectively. NKY80 is a non-nucleoside quinazolinone and regulates the AC catalytic activity in heart and lung tissues.
More description
|
|
| DC60934 | Lipid P3B Featured |
P3B is a biodegradable ionizable lipid engineered to function as a highly efficient delivery vehicle for genome-editing machinery (e.g., CRISPR-Cas9 and adenine base editors) specifically to the central nervous system (CNS). Its primary function is to encapsulate and transport large mRNA payloads across the brain-CSF interface following intrathecal administration, enabling robust and widespread gene editing in neurons and astrocytes across multiple brain regions, including the hippocampus, cortex, and thalamus. Notably, it facilitates precise single-nucleotide correction via base editing. Its targeting is intrinsically achieved by the intrathecal injection route, which localizes the nanoparticles within the cerebrospinal fluid, coupled with an optimized formulation that promotes efficient uptake and activity within CNS parenchyma while minimizing off-target exposure in peripheral organs.
More description
|
|
| DC10492 | ACSS2 inhibitor Featured |
ACSS2 inhibitor is a novel ACSS2 inhibitor.
More description
|
|
| DC68240 | WMK-1 Featured |
WMK-1 is a 1,2,4,5-tetraoxane derivative and ferroptosis inducer, with significantly higher cytotoxicity against cancer cells than non-cancerous cells. WMK-1 triggers ferroptosis in cancer cells and cancer stem cells. WMK-1 can be used for the research of cancer.
More description
|
|
| DC81740 | JNUTS013 |
JNUTS013 is a NLRP3 inflammasome inhibitor. JNUTS013 promotes proteasome-dependent degradation of NLRP3 and inhibits the release of downstream cytokines. JNUTS013 downregulates the expression of inflammation-related proteins including iNOS and COX-2.
More description
|
|
| DC68239 | WMK-2 Featured |
WMK-2 is a 1,2,4,5-tetraoxane derivative and ferroptosis inducer with broad-spectrum anticancer activity. WMK-2 generates hydroxyl radicals and lipid ROS to induce ferroptosis in cancer cells and cancer stem cells.
More description
|
|
| DCQ-011 | 10-Hydroxycamptothecin Featured |
>98%,Standard References
More description
|
|
| DC46894 | (S)-ATPO Featured |
(S)-ATPO is the (S)-enantiomer of ATPO, which is a competitive antagonist at GluR1-4 (AMPA-preferring) receptors.
More description
|
|
| DC38095 | (R)-Ofloxacin Featured |
(R)-Ofloxacin is a R-isomer of Ofloxacin, which is an antibiotic useful for the treatment of a number of bacterial infections.
More description
|
|